Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2006 Jul 19;2006(3):CD001442.
doi: 10.1002/14651858.CD001442.pub2.

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS

S Rueda, L Y Park-Wyllie, A M Bayoumi, A M Tynan, T A Antoniou, S B Rourke, R H Glazier
Meta-Analysis

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS

S Rueda et al. Cochrane Database Syst Rev. .

Abstract

Background: Adherence to prescribed regimens is required to derive maximal benefit from many highly active antiretroviral therapy (HAART) regimens in people living with HIV/AIDS.

Objectives: To conduct a systematic review of the research literature on the effectiveness of patient support and education to improve adherence to HAART.

Search strategy: A systematic search of electronic databases was performed from January 1996 to May 2005.

Selection criteria: Randomized controlled trials examining the effectiveness of patient support and education to improve adherence to HAART were considered for inclusion. Only those studies that measured adherence at a minimum of six weeks were included.

Data collection and analysis: Study selection, quality assessments and data abstraction were performed independently by two reviewers.

Main results: Nineteen studies involving a total of 2,159 participants met criteria for inclusion. It was not possible to conduct a meta-analysis due to study heterogeneity with respect to populations, interventions, comparison groups, outcomes, and length of follow-up. Sample sizes ranged from 22 to 367. The populations studied ranged from general HIV-positive populations to studies focusing exclusively on children, women, Latinos, or adults with a history of alcohol dependence, to studies focusing almost exclusively on men. Study interventions included cognitive behavioral therapy, motivational interviewing, medication management strategies, and interventions indirectly targeting adherence, such as programs directed to reduce risky sexual behaviours. Ten studies demonstrated a beneficial effect of the intervention on adherence. We found that interventions targeting practical medication management skills, those administered to individuals vs groups, and those interventions delivered over 12 weeks or more were associated with improved adherence outcomes. We also found that interventions targeting marginalized populations such as women, Latinos, or patients with a past history of alcoholism were not successful at improving adherence. We were unable to determine whether effective adherence interventions were associated with improved virological or immunological outcomes. Most studies had several methodological shortcomings leaving them vulnerable to potential biases.

Authors' conclusions: We found evidence to support the effectiveness of patient support and education interventions intended to improve adherence to antiretroviral therapy. Interventions targeting practical medication management skills, those interventions administered to individuals vs groups, and those interventions delivered over 12 weeks or more were associated with improved adherence outcomes. There is a need for standardization and increased methodological rigour in the conduct of adherence trials.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Quality assessment.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Berrien 2004 {published data only}
    1. Berrien VM, Salazar JC, Reynolds E, McKay K. Adherence to antiretroviral therapy in HIV‐infected pediatric patients improves with home‐based intensive nursing intervention. AIDS Patient Care STDS 2004;18(6):355‐363. - PubMed
DiIorio 2003 {published data only}
    1. DiIorio C, Resnicow K, McDonnell M, Soet J, McCarty F, Yeager K. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. Journal of the Assoc of Nurses in AIDS Care 2003;14(2):52‐62. - PubMed
Fairley 2003 {published data only}
    1. Fairley CK, Levy R, Rayner CR, Allardice K, Costello K, et al. Randomized trial of an adherence proramme for clients with HIV. International Journal of STD & AIDS 2003;14:805‐809. - PubMed
Goujard 2003 {published data only}
    1. Goujard C, Bernard N, Sohier N, et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr 2003;34:191‐194. - PubMed
Jones 2003 {published data only}
    1. Jones DL, Ishii M, LaPerriere A, Stanley H, Antoni M, Ironson G, et al. Influencing medication adherence among women with AIDS. AIDS CARE 2003;15(4):463‐474. - PubMed
Knobel 1999 {published data only}
    1. Knobel H, Carmona A, Lopez JL, Gimeno JL, Saballs P, Gonzalez A, Guelar A, Diez A. Adherence to highly active antiretroviral treatment: impact of individualized assessment [Adherencia al tratamiento antirretroviral de gran actividad: impacto de una intervencion de asesoramiento individualizado]. Enfermedades Infecciosas y Microbiologia Clinica 1999;17:78‐81. - PubMed
Levy 2004 {published data only}
    1. Levy RW, Rayner CR, Fairley CK, et al. Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDS 2004;18:728‐735. - PubMed
Murphy 2002 {published data only}
    1. Murphy DA, Lu Michael C, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV‐positive patients. Journal of the Association of Nurses in AIDS Care 2002;13(6):57‐69. - PubMed
Pradier 2003 {published data only}
    1. Pradier C, Bentz L, Spire B, Tourette‐Turgis C, Morin M, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials 2003;4(2):121‐131. - PubMed
Rathbun 2005 {published data only}
    1. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in the treatment of HIV infection: a prospective, randomized, controlled pilot study. Clinical Therapeutics 2005;27(2):199‐209. - PubMed
Rawlings 2003 {published data only}
    1. Rawlings MK, Thompson MA, Farthing CF, Brown LS, Racine J, et al. Impact of an educational program on efficacy and adherence with a twice‐daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV‐infected patients. J Acquir Immune Defic Syndr 2003;34(2):174‐183. - PubMed
Safren 2001 {published data only}
    1. Safren SA, et al. Two strategies to increase adherence to HIV antiretroviral medication: life‐steps and medication monitoring. Behaviour Research & Therapy 2001;39(10):1151‐62. - PubMed
Safren 2003 {published data only}
    1. Safren, SA, et al. Use of an on‐line pager system to increase adherence to antiretroviral medications. Aids Care 2003;15(6):787‐793. - PubMed
Samet 2005 {published data only}
    1. Samet JH, Horton NJ, Meli S, Dukes K, Tripp T, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antiviral Therapy 2005;10(1):83‐93. - PubMed
Smith 2003 {published data only}
    1. Smith SR, Rublein JC, Marcus C, Brock TP, Chesney MA. A medication self‐management program to improve adherence to HIV therapy regimens. Patient Education and Counseling 2003;50:187‐199. - PubMed
Tuldra 2000 {published data only}
    1. Tuldra A, et al. Prospective randomized two‐arm controlled study to determine the efficacy of a specific intervention to improve long‐term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000;25(3):221‐8. - PubMed
van Servellen 2003 {published data only}
    1. Servellen G, Carpio F, Lopez M, et al. Program to enhace health literacy and treatment adherence in low‐income HIV‐infected Latino men and women. AIDS Patient Care STDS 2003;17:581‐594. - PubMed
Weber 2004 {published data only}
    1. Weber R, Christen L, Christen S, Tschopp S, Znoj Hansjoerg, Schnedier C, et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antiviral Therapy 2004;9(1):85‐95. - PubMed
Wyatt 2004 {published data only}
    1. Wyatt GE, Longshore D, Chin D, et al. The efficacy of an integrated risk reduction intervention for HIV‐positive women with child sexual abuse histories. AIDS and Behavior 2004;8:453‐462. - PubMed

References to studies excluded from this review

Adamian 2004 {published data only}
    1. Adamian MS, Golin CE, Shain LS, DeVellis B. Brief motivational interviewing to improve adherence to antiretroviral therapy: development and qualitative pilot assessment of an intervention. AIDS Patient Care and STDs 2004;18(4):229‐. - PubMed
Albert 1999 {published data only}
    1. Albert SM, Weber CM, Todak G, Polanco C, Clouse R, et al. An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior 1999;3(2):121‐128.
Aloisi 2002 {published data only}
    1. Aloisi MS, Arici C, Balzano R, Noto P, Piscopo R, et al. Behavioral correlates of adherence to antiretroviral therapy. JAIDS 2002;31:S145‐S148. - PubMed
Altice 2004 {published data only}
    1. Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, et al. Developing a directly administered antiretroviral therapy intervention for HIV‐infected drug users: implications for program replication. Clinical Infectious Diseases 2004;38:S376‐87. - PubMed
Ammassari 2002 {published data only}
    1. Ammassari A, Antinori A, Cozzi‐Lepri A, Trotta MP, Nasti G, et al. Relationship between HAART adherence and adipose tissue alterations. JAIDS 2002;31:S140‐S144. - PubMed
Ammassari 2002 (a) {published data only}
    1. Ammassari A, Trotta MP, Murri R, Castelli F, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published liteature. JAIDS 2002;31:S123‐S127. - PubMed
Bamberger 2000 {published data only}
    1. Bamberger JD, Unick J, Klein P, Fraser M, Chesney M, Katz MH. Helping the urban poor stay with antiretroviral HIV drug therapy. Am J Public Health 2000;90(5):699‐701. - PMC - PubMed
Bangsberg 2002 {published data only}
    1. Bangsberg DR, Bronstone A, Chesney MA, Hecht FM. Computer‐assisted self‐interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. JAIDS 2002;31:S107‐S111. - PubMed
Barreiro 2002 {published data only}
    1. Barreiro P, Garcia‐Benayas T, Soriano V, Gallant J. Simplification of antiretroviral treatment ‐ how to sustain success, reduce toxicity and ensure adherence avoiding PI use. AIDS Review 2002;4:233‐241. - PubMed
Bouhnik 2002 {published data only}
    1. Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, et al. Nonadherence among HIV‐infected injecting drug users: the impact of social instability. JAIDS 2002;31:S149‐153. - PubMed
Broadhead 2002 {published data only}
    1. Broadhead RS, Heckathorn DD, Altice FL, Hulst Y, Carbone M, et al. Increasing drug users' adherence to HIV treatment: results of a peer‐driven intervention feasibility study. Social Science and Medicine 2002;55:235‐46. - PubMed
Cegala 2000 {published data only}
    1. Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med 2000;j9:57‐. - PubMed
Chesney 1999 {published data only}
    1. Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999;13(Suppl A):S271‐S278. - PubMed
DeFino 2004 {published data only}
    1. DeFino M, Clark J, Mogyoros D, Shuter J. Predictors of virologic success in patients completing a structured antiretroviral adherence program. Journal of the Assoc of Nurses in AIDS Care 2004;15(5):60‐67. - PubMed
Dorz 2003 {published data only}
    1. Dorz S, Lazzarini L, Cattelan A, Meneghetti F, Novara C, et al. Evaluation of adherence to antiretroviral therapy in Italian HIV patients. AIDS Patient Care and STDs 2003;17(1):33‐41. - PubMed
Dunbar 2003 {published data only}
    1. Dunbar PJ, Madigan D, Grohskope LA, Revere D, Woodward J, et al. A two‐way messaging system to enhance antiretroviral adherence. J of the Am Medical Informatics Association 2003;10(1):11‐15. - PMC - PubMed
Flandre 2002 {published data only}
    1. Flandre P, Peytavin G, Meiffredy V, Saidi Y, Descamps D, et al. Adherence to antiretroviral therapy and outcomes in HIV‐infected patients enrolled in an induction/maintenance randomized trial. Antiviral Therapy 2002;7(2):113‐121. - PubMed
Fogarty 2002 {published data only}
    1. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Education and Counselling 2002;46:93‐108. - PubMed
Fourney 2003 {published data only}
    1. Fourney AM, Williams ML. Formative evaluation of an intervention to increase compliance to HIV therapies: the ALP project. Health Promotion Practice 2003;4(2):165‐170. - PubMed
Frick 2001 {published data only}
    1. Frick PA, Lavreys L, Mandaliya K, Kreiss JK. Impact of an alarm device on medication compliance in women in Mombasa, Kenya. Intl J of STD & AIDS 2001;12:329‐333. - PubMed
Garcia 2003 {published data only}
    1. Garcia PB, Lahoz JG, Vazquez VS. Optimization of adherence to antiretroviral therapy [Optimizacion de la adherencia al tratamiento antirretrovirico]. Rev Clin Esp 2003;203(6):299‐302. - PubMed
GarciaP 2003 {published data only}
    1. Garcia PR, Cote JK. Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. Journal of the Assocation of Nurses in AIDS Care 2003;14(4):37‐45. - PubMed
GarciaR 2003 {published data only}
    1. Garcia R, Schooley RT, Badaro R. An adherence trilogy is essential for long‐term HAART success. Brazilian Journal of Infectious Diseases 2003;7(5):307‐314. - PubMed
Gifford 1998 {published data only}
    1. Gifford AL, Laurent DD, Gonzales VM, Chesney MA, Lorig KR. Pilot randomized trial of education to improve self‐management skills of men with symptomatic HIV/AIDS. JAIDS 1998;18(2):136‐44. - PubMed
Greenberg 1999 {published data only}
    1. Greenberg B, Berkman A, Thomas R, Hoos D, Finkelstein R, Astemborski J, Vlahov D. Evaluating supervised HAART in late‐stage HIV among drug users: a preliminary report. Journal of Urban Health: Bulletin of the New York Academy of Medicine 1999;76(4):468‐480. - PMC - PubMed
Guarinieri 2002 {published data only}
    1. Guarinieri M. Highly active antiretroviral therapy adherence: the patient's point of view. JAIDS 2002;31:S167‐S169. - PubMed
Haddad 2000 {published data only}
    1. Haddad M, Inch C, Glazier RH, Wilkins AL, Urbshott GB, Bayoumi A, Rourke S. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS (Cochrane Review). Cochrane Library 2000;3:CD001442. - PubMed
Haubrich 1999 {published data only}
    1. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, et al. The value of patient‐reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13(9):1099‐1107. - PubMed
Holzemer 2000 {published data only}
    1. Holzemer WL, Henry SB, Portillo CJ, Miramontes H. The client adherence profiling intervention tailoring (CAP‐IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study. J Assoc Nurses AIDS Care 2000;11(1):36‐44. - PubMed
Ickovics 2002 {published data only}
    1. Ickovics JR, Meade CS. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care 2002;14(3):309‐318. - PubMed
Ickovics 2002a {published data only}
    1. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. JAIDS 2002;31:98‐102. - PubMed
Ironson 2005 {published data only}
    1. Ironson G, Weiss S, Lydston D, Ishii M, Jones D, et al. The impact of improved self‐efficacy on HIV viral load and distress in culturally diverse women living with AIDS: the SMART/EST Women's Project. AIDS Care 2005;17(2):222‐236. - PubMed
Jane 2004 {published data only}
    1. Jane CC, MT Creus, OI Barrueta, OD Sanchez, OM Echevarria, et al. Evaluation of a pharmaceutical program aimed at improving adherence to antiretroviral therapy [Evaluacion de un programa de atencion farmaceutica dirigido a mejorar la adherencia al tratamiento antiretroviral]. Farm Hosp (Madrid) 2004;28(Suppl 1):19‐26. - PubMed
Kalichman 2003 {published data only}
    1. Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect 2003;79:59‐61. - PMC - PubMed
Khanlou 2003 {published data only}
    1. Khanlou H, Kandula VR, Yeh V, Stein TG, Sanchez S, et al. Pilot study of directly observed therapy in highly nonadherenct HIV‐infected patients in an urban community‐based institution. JAIDS 2003;33(5):651‐653. - PubMed
Knobel 2001 {published data only}
    1. Knobel H, Guelar A, Carmona A, Espona M, Gonzalez A, et al. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care and STDs 2001;15(4):193‐199. - PubMed
Knobel 2004 {published data only}
    1. Knobel H, Guela A. Strategies to optimize the adherence to antiretroviral treatment. Therapeutic interventions [Estrategias para optimizar la adherencia al traitamiento antirretroviral. Intervenziones en la pauta terapeutica]. Enfermedades Infecciosas y Microbiologia Clinica 2004;22(2):106‐12. - PubMed
Lanzafame 2000 {published data only}
    1. Lanzafame M, Trevenzoli M, Cattelan AM, Rovere P, Parrinello A. Directly observed therapy in HIV therapy: a realistic perspective?. JAIDS 2000;25(2):200‐201. - PubMed
Lucas 2002 {published data only}
    1. Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?. AIDS Patient Care and STDs 2002;16(11):527‐535. - PubMed
Lucas 2004 {published data only}
    1. Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clinical Infectious Diseases 2004;38:S409‐13. - PubMed
Lyon 2003 {published data only}
    1. Lyon ME, Trexler C, Akpan‐Townsend C, Pao M, Selden K, et al. A family group approach to increasing adherence to therapy in HIV‐infected youths: results of a pilot project. AIDS Pt Care and STDs 2003;17(6):299‐308. - PubMed
Macalino 2004 {published data only}
    1. Macalino GE, Mitty JA, Bazerman LB, Singh K, McKenzie M, Flanigan T. Modified directly observec therapy for the treatment of HIV‐seropositive substance users: lessons learned from a pilot study. Clinical Infectious Diseases 2004;38:S393‐7. - PubMed
Malow 1998 {published data only}
    1. Malow RM, McPherson S, Klimas N, Antoni MH, Schneiderman N, Penedo FJ, Zaskind D, Page B, McMahon R. Adherence to complex combination antiretroviral therapies by HIV positive drug abusers. Psychiatr Serv 1998;49:1021‐1022. - PubMed
Mann 2001 {published data only}
    1. Mann T. Effects of future writing and optimism on health behaviors in HIV‐infected women. Ann Behav Med 2001;23(1):26‐33. - PubMed
Margolin 2003 {published data only}
    1. Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual‐guided risk reduction intervention for HIV‐positive injection drug users. Health Psychology 2003;22(2):223‐228. - PubMed
Martin 2001 {published data only}
    1. Martin J, Sabugal GM, Rubio R, Sainz‐Maza M, Blanco JM, Alonso JL, Dominguez J. Outcomes of a health education intervention in a sample of patients infected by HIV, most of them injection drug users: possibilities and limitations. AIDS CARE 2001;13(4):467‐473. - PubMed
McCance‐Katz 2002 {published data only}
    1. McCance‐Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J on Addictions 2002;11:271‐278. - PubMed
McDonald 2002 {published data only}
    1. McDonald HP, Garg AX, Haynes RB. Review: evidence on the effectiveness of interventions to assist patients' adherence to prescribed medications is limited. JAMA 2002;288:2868‐79. - PubMed
McPherson‐Baker 2000 {published data only}
    1. McPherson‐Baker S, Malow RM, Penedo F, et al. Enhancing adherence to combination antiretroviral therapy in non‐adherent HIV‐positive men. AIDS Care 2000;12:399‐404. - PubMed
Molassiotis 2003 {published data only}
    1. Molassiotis A, Lopez‐Nahas V, Chung WY, Lam SW. A pilot study of the effects of a behavioural intervention on treatment adherence in HIV‐infected patients. AIDS Care 2003;15(1):125‐135. - PubMed
Murri 2002 {published data only}
    1. Murri R, Antinori A, Ammassari A, Nappa S, Orofino G, Abrescia N, Ussini. Physician estimate of adherence and the patient‐physician relationship as a setting to improve adherence to antiretroviral therapy. JAIDS 2002;31:S158‐S162. - PubMed
Orrell 2003 {published data only}
    1. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003;17(9):1369‐1375. - PubMed
Palepu 2004 {published data only}
    1. Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV‐infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction 2004;99:361‐368. - PubMed
Park‐Wyllie 2003 {published data only}
    1. Park‐Wyllie LY, Phillips EJ. Challenges of adherence management in human immunodeficiency virus pharmacotherapy. Canadian Journal of Clinical Pharmacology 2003;10(4):189‐195. - PubMed
Parsons 2005 {published data only}
    1. Parsons JT, Rosof E, Punzalan JC, DiMaria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance abuse use among HIV‐positive men and women: results of a pilot project. AIDS Patient Care and STDs 2005;19(1):31‐39. - PubMed
Paterson 2002 {published data only}
    1. Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. JAIDS 2002;31:S103‐S106. - PubMed
Perno 2002 {published data only}
    1. Perno CF, Ceccherini‐Silberstein F, Luca A, Cozzi‐Lepri A, Gori C, Cingolani A, et al. Virologic correlates of adherence to antiretroviral medications and therapeutic failure. JAIDS 2002;31:S118‐S122. - PubMed
Poppa 2004 {published data only}
    1. Poppa A, Davidson O, Deutsch J, Godfrey D, Fisher M, Head S, et al. British HIV association (BHIVA)/British association for sexual health and HIV (BASHH) guidelines for provision of adherence support to individuals receiving antiretroviral therapy. BHIVA 2004;5(Suppl. 2):46‐60. - PubMed
Press 2002 {published data only}
    1. Press N, Tyndall MW, Wood E, Hogg RS, Montaner JSG. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. JAIDS 2002;31:S112‐S117. - PubMed
Reynolds 2004 {published data only}
    1. Reynolds NR. Adherence to antiretroviral therapies: state of the science. Current HIV Research 2004;2:207‐214. - PubMed
Rigsby 2000 {published data only}
    1. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue‐dose training with monetary reinforcement. J Gen Intern Med 2000;15:841‐847. - PMC - PubMed
Safren 1999 {published data only}
    1. Safren SA, Otto MW, Worth JL. Life‐steps: applying cognitive behavioral therapy to HIV medication adherence. Cognitive and Behavioral Practice 1999;6:332‐341.
Schroeder 2004 {published data only}
    1. Schroeder K, Fahey T, Ebrahim S, Peters TJ. Adherence to long‐term therapies: recent WHO report provides some answers but poses even more questions. Journa of Clinical Epidemiology 2004;57:2‐3. - PubMed
Selnes 2002 {published data only}
    1. Selnes, OA. Neurocognitive aspects of medication adherence in HIV infection. JAIDS 2002;31:S132‐S135. - PubMed
Simoni 2003 {published data only}
    1. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Topics in HIV Medicine 2003;11(6):185‐198. - PubMed
Sommers 2001 {published data only}
    1. Sommers SD, Kent DJ, Beam B, Boles M, Antoniskis D. A team approach to address antiretroviral therapy adherence barriers in a managed care organization. J Managaed Care Pharm 2001;7(3):214‐218.
Sorensen 1998 {published data only}
    1. Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M. Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care 1998;10:297‐312. - PubMed
Stenzel 2001 {published data only}
    1. Stenzel MS, McKenzie M, Adelson‐Mitty J, Flanigan TP. Enhancing adherence to HAART: a pilot program of modified directly observed therapy. The AIDS Reader 2001;11(6):317‐28. - PubMed
Stone 2004 {published data only}
    1. Stone VE, Smith KY. Improving adherence to HAART. Supplement to the Journal of the National Medical Association 2004;96(Suppl. 2):27S‐29S. - PMC - PubMed
Sullivan 2004 {published data only}
    1. Sullivan LE, Fiellin DA. Hepatitis C and HIV infections: implications for clinical care in injection drug users. The American Journal on Addictions 2004;13:1‐20. - PubMed
Tesoriero 2003 {published data only}
    1. Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, et al. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. JAIDS 2003;33:484‐493. - PubMed
Trotta 2002 {published data only}
    1. Trotta MP, Ammassari A, Melzi S, Zaccarelli M, Ladisa N, Sighinolfi L, Mura MS, et al. Treatment‐related factors and highly active antiretroviral therapy adherence. JAIDS 2002;31:S128‐S131. - PubMed
Tucker 2003 {published data only}
    1. Tucker JS, Burnam MA, Sherbourne CD, Kung F‐Y, Gifford AL. Substance abuse and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine 2003;114:573‐580. - PubMed
Tuldra 2002 {published data only}
    1. Tuldra A, Wu AW. Interventions to improve adherence to antiretroviral therapy. JAIDS 2002;31(Suppl. 3):S154‐S157. - PubMed
Wagner 2002 {published data only}
    1. Wagner GJ, Ghosh‐Dastidar B. Electronic monitoring: adherence assessment or intervention?. HIV Clin Trials 2002;3(1):45‐51. - PubMed
Wagner 2002a {published data only}
    1. Wagner G, Iguchi M, Schneider S, Scott J, Anderson D. Placebo practice trials: a tool to assess and improve adherence readiness. HIV Clin Trials 2002;3(6):475‐481. - PubMed
Wagner 2003 {published data only}
    1. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care and STDs 2003;17(4):179‐186. - PubMed
Weiss 2003 {published data only}
    1. Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. HIV‐related knowledge and adherence to HAART. AIDS Care 2003;15(5):673‐679. - PubMed
Wohl 2004 {published data only}
    1. Wohl AR, Garland WH, Squires K, Witt M, Larsen R, et al. The feasibility of a community‐based directly administered antiretroviral therapy program. Clinical Infectious Diseases 2004;38(Suppl. 5):S388‐92. - PubMed
Wu 2002 {published data only}
    1. Wu AW, Ammassari A, Antinori A. Adherence to antiretroviral therapy: where are we and where do we go from here?. JAIDS 2002;31:S95‐S97. - PubMed
Yun 2005 {published data only}
    1. Yun L, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV‐infected patients. J Acquir Immune Defic Syndr 2005;38(4):432‐. - PubMed

Additional references

Altman 2001
    1. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Annals of Internal Medicine 2001;134:663‐694. - PubMed
Amico 2006
    1. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions ‐ A research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006;41:285‐297. - PubMed
Ammassari 2002
    1. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr 2002;31(3):S123‐127. - PubMed
Bangsberg 2000
    1. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV‐1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357‐366. - PubMed
Bangsberg 2001
    1. Bangsberg DR, Perry S, Charlebois ED, et al. Non‐adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181‐1183. - PubMed
Bangsberg 2002
    1. Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough?. Journal of General Internal Medicine 2002;17(10):812‐813. - PMC - PubMed
Carpenter 2000
    1. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society‐USA Panel. JAMA 2000;283:381‐390. - PubMed
Catz 2000
    1. Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology 2000;19:124‐133. - PubMed
Cote 2005
    1. Cote JK, Godin G. Efficacy of interventions in improving adherence to antiretroviral therapy ‐ Review. International Journal of STD & AIDS 2005;16:335‐343. - PubMed
Ferguson 2002
    1. Feguson TF, Stewart KE, Funkhouser E, et al. Patient‐perceived barriers to antiretroviral adherence: associations with race. AIDS Care 2002;14:607‐617. - PubMed
Fogarty 2002
    1. Fogarty L, Roter D, Larson S, et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns 2002;46:93‐108. - PubMed
Gallant 1998
    1. Gallant J, Block D. Adherence to antiretroviral regimens in HIV‐infected patients: results of a survey among physicians and patients. Journal of the International Association of Physicians in AIDS Care 1998;4:32‐35. - PubMed
Golin 2002
    1. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine 2002;17:756‐765. - PMC - PubMed
Gross 2001
    1. Gross R, Bilker WB, Friedman HM, et al. Effects of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001;15:2109‐2117. - PubMed
Haddad 2000
    1. Haddad M, Inch C, Glazier RH, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev 2000;3:CD001442. - PubMed
Haubrich 1999
    1. Haubrich RH, Little SJ, Currier JS, et al. The value of patient‐reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13:1099‐1107. - PubMed
Haynes 1979
    1. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Compliance in health care. Baltimore, MD: John Hopkins University Press, 1979.
Howard 2002
    1. Howard AA, Arnsten JH, Li YT, et al. A prospective study of adherence and viral load in a large multi‐center cohort of HIV‐infected women. AIDS 2002;16:2175‐2182. - PubMed
Hugen 2002
    1. Hugen PWH, Langebeek N, Burger DM, et al. Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.. Journal of Acquired Immune Deficiency Syndromes 2002;30:324‐334. - PubMed
Ickovics 1997
    1. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. Journal of Clinical Epidemiology 1997;50:385‐391. - PubMed
Ickovics 2002
    1. Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antiviral Therapy 2002;7:185‐193. - PubMed
Ickovics 2002a
    1. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr 2002;31(3):S98‐102. - PubMed
Kawamoto 2005
    1. Kawamoto K, Houlihan CA, Balas EA, et al. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. British Medical Journal 2005;330:765‐768E. - PMC - PubMed
Knobel 2001
    1. Knobel H, Guelar A, Carmona A, et al. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care STDS 2001;15:193‐199. - PubMed
Liu 2001
    1. Liu H, Golin C, Miller L, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968‐977. - PubMed
McDonald 2002
    1. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions ‐ Scientific review. JAMA 2002;288:2868‐2879. - PubMed
Miller 2000
    1. Miller L, Hays R. Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials 2000;1:36‐46. - PubMed
Moher 2001
    1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomised trials. The Lancet 2001;357:1191‐1194. - PubMed
Nieuwkerk 2001
    1. Nieuwkerk PT, Sprangers MAG, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV‐1 infection in an observational cohort study. Archives of Internal Medicine 2001;161:1962‐1968. - PubMed
Paterson 2000
    1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21‐30. - PubMed
Perno 2002
    1. Perno CF, Ceccherini‐Silberstein F, Luca A, et al. Virologic correlates of adherence to antiretroviral medications and therapeutic failure. J Acquir Immune Defic Syndr 2002;31(3):S118‐122. - PubMed
Press 2002
    1. Press N, Tyndall MW, Wood E, et al. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002;31(3):S112‐117. - PubMed
Sackett 1979
    1. Sackett DL, Snow LC. The magnitude of adherence and nonadherence. In: Haynes RB, Taylor DW, Sackett DL editor(s). Compliance in Health Care. John Hopkins University Press, 1979:11‐22.
Schulz 1995
    1. Schulz K, Chalmers I, Hayes R, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408‐412. - PubMed
Simoni 2003
    1. Simoni JM, Frick PA, Pantalone DW, et al. Antriretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med 2003;11:185‐198. - PubMed
Simoni 2006
    1. Simoni JM, Pantalone DW, Frick PA, et al. Enhancing antiretroviral adherence: A review of published reports of RCTs and on‐going NIH‐funded research. In: Trafton JA, Gordon WP, eds. Best Practices in the Behavioral Management of Chronic Disease. Los Altos: Institute for Disease Management, 2006.
Singh 1999
    1. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus‐infected patients to antiretroviral therapy. Clinical Infectious Diseases 1999;29:824‐830. - PubMed
Wainberg 1998
    1. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977‐1983. - PubMed
Wood 2003
    1. Wood E, Hogg RS, Yip B, et al. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. AIDS 2003;17:711‐720. - PubMed
Yeni 2002
    1. Yeni PG, Hammer SM, Carpenter CC, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society‐USA Panel [Erratum appears in JAMA 2003 Jan‐Feb; 11(1):32]. JAMA 2002;11:222‐235. - PubMed
Yeni 2004
    1. Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society‐USA Panel. JAMA 2004;292:251‐265. - PubMed

MeSH terms